EMA Authorised: Nintedanib Viatris (nintedanib) — Viatris Limited

View source ↗

Summary

The European Medicines Agency authorised a generic version of nintedanib (Nintedanib Viatris) for idiopathic pulmonary fibrosis and related interstitial lung di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Pulmonary Fibrosis

Drugs mentioned

• Nintedanib Viatris (nintedanib)

Snippet

Status: Authorised. Therapeutic area: Idiopathic Pulmonary Fibrosis;Lung Diseases, Interstitial;Pulmonary Fibrosis. MAH: Viatris Limited. Decision date: 22/08/2025